Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study to Assess Preoperative Hypofractionated Stereotactic Radiotherapy of Brain Metastases

NCT04503772 is registered in ClinicalTrials.gov with Centre Jean Perrin as lead sponsor.

NCT NCT04503772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04503772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study to Assess Preoperative Hypofractionated Stereotactic Radiotherapy of Brain Metastases
Lead sponsor
Centre Jean Perrin
Phase
Phase 2
Overall status
Completed
Start date
February 4, 2021
Completion date
November 25, 2025
Enrollment
70 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases